혈관내 스텐트 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 제품별, 최종 용도별, 지역별＆경쟁(2021-2031년)

The Global Intravascular Stents Market is projected to expand from a valuation of USD 13.22 Billion in 2025 to USD 20.28 Billion by 2031, registering a CAGR of 7.39% during this period. These devices, which are expandable mesh tubes utilized to reopen narrowed or blocked arteries, are essential for restoring blood flow and ensuring vessel patency. The primary growth factors include a rapidly aging global population and a growing incidence of cardiovascular diseases, which increase the necessity for interventional procedures to treat conditions like coronary artery disease. Data from the European Society of Cardiology indicates that in 2024, cardiovascular disease caused more than 3 million deaths annually across member nations, underscoring the urgent and continuing need for effective therapeutic solutions.

Conversely, the market encounters significant hurdles arising from strict regulatory frameworks regarding safety standards and product approvals. Regulatory bodies mandate exhaustive clinical testing, which prolongs development timelines and increases manufacturing costs before devices can enter the commercial market. Furthermore, the risk of product recalls triggered by adverse events, such as thrombosis, poses a serious threat to brand reputation and can delay the market adoption of emerging technologies.

Market Driver

The rising global prevalence of cardiovascular diseases acts as the main driver for the intravascular stents industry, necessitating a higher volume of angioplasty procedures to treat arterial obstructions. As poor dietary choices and sedentary lifestyles become more widespread, rates of coronary artery disease are increasing, requiring mechanical interventions to maintain adequate blood flow. According to the 'Vital Statistics Rapid Release' report published by the Centers for Disease Control and Prevention in September 2025, heart disease remained the primary cause of mortality in 2024, responsible for 683,037 deaths in the United States alone. This ongoing health burden ensures steady demand for therapeutic devices, a trend reflected in industry performance; Medtronic's 'Fiscal Year 2025 Annual Report' from June 2025 noted that their Cardiovascular Portfolio achieved $12.5 billion in net sales, highlighting the critical global need for these interventions.

Additionally, technological innovations in stent materials and design represent a significant growth driver, with manufacturers launching next-generation devices that enhance patient recovery and broaden the treatable population. Developments such as drug-eluting technologies and bioresorbable scaffolds have notably lowered the risks of thrombosis and restenosis compared to earlier bare-metal models, enabling physicians to address peripheral vascular conditions and complex lesions that were previously challenging to treat. Continuous R&D investment is generating substantial returns for major companies; for example, Abbott's 'Fourth-Quarter and Full-Year 2024 Results' from January 2025 reported a 13.7% growth in their Medical Devices segment, fueled partly by a surge exceeding 20% in Structural Heart revenue involving advanced scaffold technologies. This product evolution encourages healthcare facilities to upgrade their supplies, thereby maintaining revenue growth and market momentum.

Market Challenge

The strict regulatory frameworks that govern safety standards and product approvals constitute a major obstacle to the expansion of the Global Intravascular Stents Market. Worldwide regulatory bodies impose demanding quality assurance and clinical testing mandates that manufacturers must fulfill prior to commercializing a device. These extensive requirements significantly prolong the product development lifecycle and elevate financial costs, frequently forcing companies to divert funds away from research and development initiatives. This complicated regulatory environment slows the introduction of innovative stent technologies and limits their availability in critical geographic regions.

Data from MedTech Europe in 2024 indicates that under the new regulatory landscape, the average timeframe for medical device certification has increased to between 13 and 18 months, while compliance costs have risen by roughly 100% compared to earlier directives. These delays and increased expenses compel manufacturers to reassess their market strategies, often resulting in the withdrawal of legacy products or the deprioritization of regions with high regulatory barriers. Consequently, the sluggish approval process directly impedes market growth and restricts the timely accessibility of advanced therapeutic options for patients suffering from cardiovascular conditions.

Market Trends

The migration of procedures toward Ambulatory Surgical Centers (ASCs) is fundamentally reshaping the procurement landscape, influenced by the demand for cost-effective healthcare and evolving reimbursement policies. Healthcare systems are increasingly moving percutaneous coronary interventions (PCIs) from inpatient hospital settings to outpatient facilities to reduce procedural costs and manage hospital capacity issues. This transition is bolstered by regulatory changes, such as the broadening of CMS covered procedure lists, which encourage providers to conduct catheter-based interventions in these more economical settings; consequently, manufacturers are adjusting their supply chains to meet the specific logistical and inventory requirements of high-volume outpatient centers. According to the 'State of the Industry Report' by HST Pathways in March 2025, cardiology represented 24% of total ASC block time utilization in 2024, indicating a rapid shift toward prioritizing vascular interventions in these facilities.

Concurrently, the integration of artificial intelligence into stent selection and sizing is transforming pre-procedural planning by improving device deployment precision. Advanced algorithms are being combined with intravascular imaging tools, like Optical Coherence Tomography (OCT), to automate the assessment of lesion characteristics and vessel dimensions. This technological advancement tackles critical issues such as stent underexpansion and malapposition, which are primary causes of restenosis and device failure. By utilizing machine learning to analyze complex imaging data, clinicians can identify the ideal landing zone and stent size with superior accuracy, enhancing long-term outcomes; a review titled 'Harnessing Artificial Intelligence in Interventional Cardiology' by the National Institutes of Health in July 2025 noted that deep learning algorithms achieved 94% accuracy in predicting incomplete stent expansion, highlighting the capacity of these tools to reduce procedural errors.

Key Market Players

• Boston Scientific Corporation
• Medtronic plc.
• Terumo Medical Corporation
• Abbott Laboratories Inc.
• BIOTRONIK SE & Co. KG
• Stryker Corporation
• Microport Scientific Corporation
• Stentys S.A.
• HELLMAN & FRIEDMAN LLC
• B. Braun SE

Report Scope

In this report, the Global Intravascular Stents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravascular Stents Market, By Type

• Drug Eluting Stents
• Bare Metal Stents
• Bioabsorbable Stents

Intravascular Stents Market, By Product

• Coronary Stents
• Peripheral Stents

Intravascular Stents Market, By End-Use

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Intravascular Stents Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravascular Stents Market.

Available Customizations:

Global Intravascular Stents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intravascular Stents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents)
  • 5.2.2. By Product (Coronary Stents, Peripheral Stents)
  • 5.2.3. By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Intravascular Stents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Intravascular Stents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Intravascular Stents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Intravascular Stents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End-Use

7. Europe Intravascular Stents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Intravascular Stents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End-Use
  • 7.3.2. France Intravascular Stents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Intravascular Stents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Intravascular Stents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Intravascular Stents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End-Use

8. Asia Pacific Intravascular Stents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Intravascular Stents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Intravascular Stents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Intravascular Stents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Intravascular Stents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Intravascular Stents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End-Use

9. Middle East & Africa Intravascular Stents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Intravascular Stents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End-Use
  • 9.3.2. UAE Intravascular Stents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End-Use
  • 9.3.3. South Africa Intravascular Stents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End-Use

10. South America Intravascular Stents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Intravascular Stents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Colombia Intravascular Stents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End-Use
  • 10.3.3. Argentina Intravascular Stents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Intravascular Stents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boston Scientific Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic plc.
• 15.3. Terumo Medical Corporation
• 15.4. Abbott Laboratories Inc.
• 15.5. BIOTRONIK SE & Co. KG
• 15.6. Stryker Corporation
• 15.7. Microport Scientific Corporation
• 15.8. Stentys S.A.
• 15.9. HELLMAN & FRIEDMAN LLC
• 15.10. B. Braun SE

16. Strategic Recommendations

17. About Us & Disclaimer